Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL375254 | 0.86 | CYP4F2 (0.33) | EPHX2 | |
| SCHEMBL15928495 | 0.81 | SMN1; SMN2 (0.37) | ALDH1A1TSHREPHX2SMN1; SMN2TDP1 | |
| SCHEMBL3292857 | 0.79 | — | — | |
| SCHEMBL375134 | 0.79 | CYP4F2 (0.31) | — | |
| SCHEMBL3643307 | 0.79 | CYP4F2 (0.31) | — | |
| SCHEMBL1635539 | 0.79 | CYP4F2 (0.31) | — | |
| SCHEMBL20348813 | 0.79 | CYP4F2 (0.33) | — | |
| SCHEMBL15928651 | 0.75 | SMN1; SMN2 (0.34) | EPHX2SMN1; SMN2 | |
| SCHEMBL16065462 | 0.73 | MEN1 (0.31) | — | |
| SCHEMBL11179315 | 0.72 | ALDH1A1 (0.37) | ALDH1A1ATMLMNAPOLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10793540-B2 | Method for producing fluorine-containing cyclopropane carboxylic acid compound | CENTRAL GLASS COMPANY, LIMITED (JP) | 2020-10-06 | — | — | US | disclosed |
| US-10450291-B2 | Method for producing fluorine-containing cyclopropane carboxylic acid compound | CENTRAL GLASS COMPANY, LIMITED (JP) | 2019-10-22 | — | — | US | disclosed |
| US-20180186763-A1 | Method for Producing Fluorine-Containing Cyclopropane Carboxylic Acid Compound | CENTRAL GLASS COMPANY, LIMITED (JP) | 2018-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793540-B2 | Method for producing fluorine-containing cyclopropane carboxylic acid compound | PFAS, FDPS, CYP2F1 | ALDH1A1 996/4885ATM 4621/4885TSHR 1142/4885 |
| US-20180186763-A1 | Method for Producing Fluorine-Containing Cyclopropane Carboxylic Acid Compound | PFAS, FDPS, FIBP | ALDH1A1 1093/4885ATM 4574/4885TSHR 1005/4885 |
| US-10450291-B2 | Method for producing fluorine-containing cyclopropane carboxylic acid compound | PFAS, FDPS, FIBP | ALDH1A1 1093/4885ATM 4574/4885TSHR 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.